ARCHIVES

EGFR Inhibitor Shrinks Tumors In Phase I Study of Patients With Treatment-Resistant Mutation

This article is from The Cancer Letter archive.

Vol. 37 No. 5 | May 30, 2014

Download PDF Visit The Full Archive

Related Articles

NIH Director Varmus Names President of Sloan-Kettering, Succeeding Mark

October 15, 1999

In Brief: NCI, EPA Award contract For Farmers study To Iowa, North Carolina; NIAID’s Hoth to Resign

January 29, 1993

Leukemia Society Seeks Applicants for Grants

December 9, 1994

Treatment Progress Stirs Up Big ASCO turnout; Reports Presented

May 14, 1976

In Turnaround, HHS Says It Will Enforce Pediatric Rule

April 26, 2002

In Brief: Hospices Urges To Develop Program For AIDs Victims; Companies Give $25,5000 To NCI Fund

November 1, 1985